MC13-0033 Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan

✍ Scribed by Eoli, M.; Calleri, A.; Bruzzone, M.G.; Anghileri, E.; Pellegatta, S.; Mancuso, P.; Di Stefanoz, A.; Bertolini, F.; Cuppini, L.; Finocchiaro, G.

• Book ID: 122329760
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 57 KB
• Volume: 49
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(13)70147-3